evidence: In 2003, he had halted his ongoing HIV work to help scientists in China combat the SARS coronavirus. He decided to again pause his laboratory’s HIV research—most recently focused on developing drugs that could be administered less frequently than the daily cocktail and engineering antibodies to cure the disease—to target this new and dangerous coronavirus. "By the second week of January, we recognized that this was a SARS-like coronavirus," says Dr. Ho, the Clyde’56 and Helen Wu Professor of Medicine at VP&S. "Given our background in HIV, we recognized that there was plenty we could bring to bear and make a contribution."